Free Trial

Oxford Biomedica (OXBDF) Stock Forecast & Price Target

$4.44
0.00 (0.00%)
(As of 07/16/2024 ET)

Oxford Biomedica - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 2 Wall Street analysts who have issued ratings for Oxford Biomedica in the last 12 months, the stock has a consensus rating of "Hold." Out of the 2 analysts, 2 have given a hold rating for OXBDF.

Consensus Price Target

N/A

According to the 2 analysts' twelve-month price targets for Oxford Biomedica,

TypeCurrent Forecast
7/18/23 to 7/17/24
1 Month Ago
6/18/23 to 6/17/24
3 Months Ago
4/19/23 to 4/18/24
1 Year Ago
7/18/22 to 7/18/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Get Oxford Biomedica Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter.

OXBDF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OXBDF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oxford Biomedica Stock vs. The Competition

TypeOxford BiomedicaMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.71
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside1,211.76% Upside7.68% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/22/2023JPMorgan Chase & Co.
3 of 5 stars
 Lower TargetGBX 495 ➝ GBX 325
9/4/2023Liberum Capital
2 of 5 stars
 DowngradeBuy ➝ Hold
8/4/2023Stifel Nicolaus
4 of 5 stars
 DowngradeBuy ➝ Hold
5/3/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight
4/25/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Pantginis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
10/11/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetGBX 1,020 ➝ GBX 1,110

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:40 PM ET.

OXBDF Forecast - Frequently Asked Questions

Should I buy or sell Oxford Biomedica stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oxford Biomedica in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OXBDF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OXBDF, but not buy additional shares or sell existing shares.

Do Wall Street analysts like Oxford Biomedica more than its competitors?

Analysts like Oxford Biomedica less than other "medical" companies. The consensus rating for Oxford Biomedica is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OXBDF compares to other companies.


This page (OTCMKTS:OXBDF) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners